Gene Therapy of ABCA4-Associated Diseases
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The ATP-binding cassette (ABC) transporter gene, ABCA4 (ABCR), was characterized in 1997 as the causal gene for autosomal recessive Stargardt disease (STGD1). Shortly thereafter several other phenotypes were associated with mutations in ABCA4, which now have collectively emerged as the most frequent cause of retinal degeneration phenotypes of Mendelian inheritance. ABCA4 functions as an important transporter (or "flippase") of vitamin A derivatives in the visual cycle. Several ways to alleviate the effects of the defective ABCA4 protein, which cause accumulation of 11-cis and all-trans-retinal in photoreceptors and lipofuscin in the retinal pigment epithelium, have been proposed. Although ABCA4 has proven to be a difficult research target, substantial progress through genetic, functional, and translational studies has allowed major advances in therapeutic applications for ABCA4-associated pathology, which should be available to patients in the (near) future. Here, we summarize the status of the gene therapy-based treatment options of ABCA4-associated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 1×
“…in small and large animal models (Stieger et al. 2010) and have paved the way to the first clinical trials using AAV in patients with Leber congenital amaurosis, a severe form of childhood blindness (Bainbridge et al. 2008; Maguire et al. 2008, 2009; Cideciyan et al. 2009; Simonelli et al. 2010).”
BackgroundSelf-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 2×
“2010) and have paved the way to the first clinical trials using AAV in patients with Leber congenital amaurosis, a severe form of childhood blindness (Bainbridge et al. 2008; Maguire et al. 2008, 2009; Cideciyan et al. 2009; Simonelli et al. 2010).”
BackgroundAllikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 2×
“Direct gene replacement represents an attractive therapeutic option also for treatment of all ABCA4-associated diseases, including Stargardt disease (STGD1) (Allikmets et al. 1997; Molday and Zhang 2010).”
BackgroundSelf-citationGene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 1×
“Most well known have been reports that a recombinant adeno-associated virus (rAAV) carrying wild-type Rpe65 (rAAV-Rpe65) improved visual function in the Briard dog model of childhood blindness (Acland et al. 2001; Narfstrom et al. 2003; Le Meur et al. 2007).”
BackgroundEffect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 8×
“In particular, injection of naked DNA via subretinal injection between the PR and retinal pigment epithelium (RPE) (Liang et al. 2000) is highly inefficient (Charbel Issa and MacLaren 2012).”
BackgroundInfluentialMaguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865 · cited 1×
“…in small and large animal models (Stieger et al. 2010) and have paved the way to the first clinical trials using AAV in patients with Leber congenital amaurosis, a severe form of childhood blindness (Bainbridge et al. 2008; Maguire et al. 2008, 2009; Cideciyan et al. 2009; Simonelli et al. 2010).”
BackgroundSelf-citationDuan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Grieger, J. C., & Samulski, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9933-9944.2005 · Cited by 419
Cited by
Viral Delivery Systems for CRISPR
Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019) · Viruses · doi:10.3390/v11010028 · Cited by 277
“More importantly, many disorders are caused by genes with sizes that exceed the packaging capacities of viral vectors, making it impossible to add full-length alleles as a method to correct the underlying disorder [8,9].”
BackgroundAn ABCA4 loss-of-function mutation causes a canine form of Stargardt disease
Mäkeläinen, S., Gòdia, M., Hellsand, M., Viluma, A., Hahn, D., Makdoumi, K., Zeiss, C. J., Mellersh, C., Ricketts, S. L., Narfström, K., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1007873 · Cited by 41
“Currently, 221 there is no standard treatment for STGD in humans and Abca4 mouse is the only available 222 animal model [51, 52].”
BackgroundStem cell-based therapy for diseases of the retinal pigment epithelium: from bench to bedside
Sachdeva, M. M., & Eliott, D. (2016) · Seminars in Ophthalmology · doi:10.3109/08820538.2015.1115253 · Cited by 28
Metadata
- Authors
- Auricchio, A., Trapani, I., & Allikmets, R.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-01-08
- Volume
- 5
- Issue
- 5
- Pages
- a017301-a017301
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2102560190
- Cited by
- 41
- References
- 33
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene Therapy of ABCA4-Associated Diseases. https://app.cochat.ai/papers/10.1101/cshperspect.a017301
- The paper
- Auricchio, A., Trapani, I., & Allikmets, R. (2015). Gene Therapy of ABCA4-Associated Diseases. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a017301
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.